TrivarX Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDBIF research report →
About the company
TrivarX Limited operates as a health technology enterprise, focusing on the creation of advanced, AI-driven, and scientifically validated instruments for the detection and diagnosis of behavioral health disorders. The company's reach extends across both Australia and the United States. Beyond its core diagnostic tools, TrivarX provides specialized mental well-being programs tailored for businesses as a corporate health solution, and also develops various products for the wider healthcare provider market.
- CEO
- Kai Sun
- IPO
- 2017
- Employees
- 6
- HQ
- Mount Lawley, WA, AU
Price Chart
- Market Cap
- $1.62M
- P/E
- -6.57
- P/S
- 0.00
- P/B
- 0.67
- EV/EBITDA
- -11.28
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -11.66%
- ROIC
- -8.85%
- Revenue
- $1.13M · 27.02%
- Net Income
- $-943,231 · 23.75%
- EPS
- $-0.00 · 52.50%
- Op Income
- $128.25K
- FCF YoY
- 95.17%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.01
- Beta
- 0.86
- Avg Volume
- 8
Get TickerSpark's AI analysis on MDBIF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our MDBIF coverage
Recent articles, reports, and earnings notes.
No research on MDBIF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MDBIF report →Similar companies
Peers in the same neighborhood.